DAILY ASPIRIN THERAPY FOR THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: A RANDOMIZED CONTROLLED TRIAL

被引：0
|
作者：
Wilechansky, Robert M. [1 ]
Stoyanova, Stefania [1 ]
Grossman, Alessandra [1 ]
Dichtel, Laura E. [1 ]
Serhan, Charles N. [2 ]
Miller, Karen K. [1 ]
Corey, Kathleen E. [1 ]
Chung, Raymond T. [1 ]
Chan, Andrew T. [1 ]
Simon, Tracey G. [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA USA
[2] Brigham & Womens Hosp, Boston, MA USA
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
144
引用
收藏
页码：S151 / S151
页数：1
相关论文
共 50 条
  • [1] Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis A Randomized Clinical Trial
    Simon, Tracey G.
    Wilechansky, Robert M.
    Stoyanova, Stefania
    Grossman, Alessandra
    Dichtel, Laura E.
    Lauer, Georg M.
    Miller, Karen K.
    Hoshida, Yujin
    Corey, Kathleen E.
    Loomba, Rohit
    Chung, Raymond T.
    Chan, Andrew T.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (11): : 920 - 929
  • [2] Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease
    Nendouvhada, Livhuwani P.
    Sibuyi, Nicole R. S.
    Fadaka, Adewale O.
    Meyer, Samantha
    Madiehe, Abram M.
    Meyer, Mervin
    Gabuza, Kwazikwakhe B.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [3] Effect of a Ketogenic Diet on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Progression: A Randomized Controlled Trial
    Chirapongsathorn, Sakkarin
    Rintaravitoon, Wiwit
    Tangjaturonrasme, Bhagawat
    Chotsriluecha, Samitti
    Pumsutas, Yanisa
    Kanchanapradith, Achariya
    Treeprasertsuk, Sombat
    JGH OPEN, 2025, 9 (01):
  • [4] Effectiveness and risks of dapagliflozin in treatment for metabolic dysfunction-associated steatotic liver disease with type 2 diabetes: a randomized controlled trial
    Fukada, Hiroo
    Kon, Kazuyoshi
    Yaginuma, Reiko
    Uchiyama, Akira
    Morinaga, Maki
    Ishizuka, Kei
    Fukuhara, Kyoko
    Okubo, Hironao
    Suzuki, Satoko
    Nojiri, Shuko
    Yamashina, Shunhei
    Ikejima, Kenichi
    FRONTIERS IN MEDICINE, 2025, 12
  • [5] Metabolic Dysfunction-Associated Steatotic Liver Disease
    Ali, Sajjadh M. J.
    Lai, Michelle
    ANNALS OF INTERNAL MEDICINE, 2025, 178 (01) : ITC1 - ITC17
  • [6] flammation inhibitor for metabolic dysfunction-associated steatotic liver disease therapy
    Kang, Wang
    Zhang, Pengfei
    Sun, Huiyong
    Cui, Shuang
    Ao, Lanjia
    Cui, Ming
    Xu, Xiaowei
    Wang, Lin
    Xu, Yuanyuan
    Wang, Guangji
    Hong, Wang
    Haiping, Hao
    CHINESE JOURNAL OF NATURAL MEDICINES, 2024, 22 (11) : 965 - 976
  • [7] Metabolic dysfunction-associated steatotic liver disease and the heart
    Driessen, Stan
    Francque, Sven M.
    Anker, Stefan D.
    Cabezas, Manuel Castro
    Grobbee, Diederick E.
    Tushuizen, Maarten E.
    Holleboom, Adriaan G.
    HEPATOLOGY, 2023,
  • [8] Metabolic dysfunction-associated steatotic liver disease in adults
    不详
    NATURE REVIEWS DISEASE PRIMERS, 2025, 11 (01):
  • [9] Metabolic dysfunction-associated steatotic liver disease and atherosclerosis
    Castillo-Nunez, Yulino
    Almeda-Valdes, Paloma
    Gonzalez-Galvez, Guillermo
    Arechavaleta-Granell, Maria del Rosario
    CURRENT DIABETES REPORTS, 2024, 24 (07) : 158 - 166
  • [10] Metabolic dysfunction-associated steatotic liver disease in adults
    Huang, Daniel Q.
    Wong, Vincent W. S.
    Rinella, Mary E.
    Boursier, Jerome
    Lazarus, Jeffrey V.
    Yki-Jarvinen, Hannele
    Loomba, Rohit
    NATURE REVIEWS DISEASE PRIMERS, 2025, 11 (01):
12345